<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>17126</id><no>BIOMAGIII</no><status>Open</status><title>Safety and Clinical Performance of the Drug Eluting &#xD;
Resorbable Coronary Magnesium Scaffold System &#xD;
(Freesolve®) in the Treatment of Subjects with de Novo &#xD;
Lesions in Native Coronary Arteries: BIOMAG-III: A &#xD;
randomized controlled trial&#xD;
</title><secondary_protocol_no>BIOMAG-III</secondary_protocol_no><nct_id>NCT07258290</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><disease_site>Other</disease_site><PI>Ben-Dor, Itsik</PI><institution>Medstar Washington Hospital Center : Eric Suchanec</institution><management_group>MCRN - Wash Interventional</management_group><item><contact_id>17606</contact_id><item_description>Eric Suchanec</item_description><js_safe_str>Eric Suchanec</js_safe_str><email>Eric.Suchanec@medstar.net</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>